Project Objectives

For the reason most of the conducted post marketing surveillance trials are lacking the means of mirroring the real world of the studied drugs with respect to safety and efficacy after marketing and dissemination to the general population and that is due to the inclusion of a limited number of patients while having a short periods of time studies, In addition to the inadequate representation of the patient populations and the direct comparison with drugs in the same therapeutic class used for the same indication; TPMC e-clinical trials project idea was born aiming to accomplish the following objectives:

- Insure the real representation of a large scale population-wide level of patients through an extremely secured, controlled and well organized high-end methodologies of studying and collecting data on efficacy, safety and ADR reporting on a wide range of - individually studied - pharmaceutical drugs throughout continued - long period - of multiple phases of this project life cycle.

- Minimize the limitations in of the clinical trials' spontaneous ADR reporting systems by insuring an adequate reporting, completion of the collected data, multiple cross checks between reported data and those in patient files to ensure a quality reported data.

- Further understanding of safety and efficacy aspects of a wide range of individually studied pharmaceutical drugs over a long period of multiple phases studies.

- Prospective monitoring of new health events in patients taking selected prescription medications.

- Examining certain studies' outcomes such as compliance, costs, and productivity.

- Helping the market analysis of related medical studied segments, product targeting, and market strategy adjustment.

- Implementing new strategies in having more chances of scientific based relations and recognition in related studied markets, as well as improving doctors' confidence in TPMC drugs.